awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q44613028-1F2F2692-0862-4204-88C0-0270A5BE17C7
Q44613028-1F2F2692-0862-4204-88C0-0270A5BE17C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44613028-1F2F2692-0862-4204-88C0-0270A5BE17C7
Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.
P2860
Q44613028-1F2F2692-0862-4204-88C0-0270A5BE17C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44613028-1F2F2692-0862-4204-88C0-0270A5BE17C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c3dc520ae499c62c1d6da9aa44aa23bc52e4e5f8
P2860
PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.